|1.||Sears, Pamela: 7 articles (05/2014 - 02/2011)|
|2.||Miller, Mark A: 7 articles (07/2013 - 02/2011)|
|3.||Cornely, Oliver A: 6 articles (11/2014 - 04/2012)|
|4.||Babakhani, Farah: 6 articles (05/2014 - 09/2011)|
|5.||Louie, Thomas J: 6 articles (08/2012 - 02/2011)|
|6.||Weiss, Karl: 6 articles (08/2012 - 02/2011)|
|7.||Crook, Derrick W: 5 articles (05/2014 - 04/2012)|
|8.||Johnson, Stuart: 4 articles (09/2014 - 02/2012)|
|9.||Gorbach, Sherwood L: 4 articles (05/2014 - 09/2011)|
|10.||Gerding, Dale N: 3 articles (09/2014 - 11/2011)|
08/01/2014 - "The macrolide antibiotic fidaxomicin was recently shown to be effective in treating CDI, and its beneficial effect was associated with fewer recurrent infections in CDI patients. "
01/01/2013 - "Fidaxomicin is less effective against infections caused by the Ribotype 027 strain, a virulent strain that is regularly encountered in the Netherlands. "
03/01/2013 - "Fidaxomicin is a novel treatment for Clostridium difficile infections (CDIs). "
02/01/2012 - "Fidaxomicin, a new treatment for Clostridium difficile infections."
09/01/2015 - "Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in vitro human gut model."
11/01/2012 - "Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea."
12/01/2014 - "Fidaxomicin is approved for the treatment of adults with Clostridium difficile-associated diarrhea, many of whom have difficulty swallowing an intact tablet. "
05/01/2014 - "Fidaxomicin (FDX) is a narrow-spectrum antibiotic for the treatment of Clostridium difficile-associated diarrhea. "
08/01/2013 - "Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis."
08/01/2012 - "Fidaxomicin is an oral anti-infective approved for the treatment of Clostridium difficile-associated diarrhea. "
07/01/2013 - "Within the cancer population, low albumin was negatively and fidaxomicin was positively associated with improved cure. "
07/01/2013 - "With fidaxomicin, median TTROD was not significantly affected by presence of cancer (74 v 54 hours; log-rank P = .145). "
11/01/2015 - "Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain."
11/01/2014 - "To report our experience with the use of fidaxomicin (FDX), an oral macrocyclic antibiotic, in cancer patients with Clostridium difficile infection (CDI). "
11/01/2014 - "The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancer."
02/01/2014 - "The fidaxomicin labeling was revised to include information about the possibility of hypersensitivity reactions. "
02/01/2014 - "Hypersensitivity reactions associated with fidaxomicin use."
02/01/2014 - "We report hypersensitivity reactions associated with fidaxomicin, an antibacterial drug approved for the treatment of Clostridium difficile-associated diarrhea. "
05/01/2014 - "Vigabatrin-Induced Encephalopathy; Fidaxomicin Hypersensitivity Reactions; Vemurafenib-Induced DRESS; Severe Alkalosis and Hypokalemia With Stanozolol Misuse; Isotretinoin-Associated Lip Abscess; Eltrombopag-Associated Hyperpigmentation."
02/01/2012 - "Literature was identified through Ovid MEDLINE (1948-December 2011) and International Pharmaceutical Abstracts (1970-December 2011) using the search terms fidaxomicin, OPT-80, PAR-101, OP-118, difimicin, tiacumicin, lipiarmycin, Clostridium difficile, Clostridium difficile infection, Clostridium difficile-associated diarrhea, and cost. "
02/01/2012 - "Key search terms included Clostridium difficile, Clostridium infections, pseudomembranous colitis, antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, elderly, geriatric, epidemiology, microbiology, diagnosis, risk factors, treatment, drug therapy, vancomycin, metronidazole, and fidaxomicin. "
|4.||Anti-Bacterial Agents (Antibiotics)
|5.||DNA-Directed RNA Polymerases (RNA Polymerase)
|1.||Transplantation (Transplant Recipients)
|3.||Hematopoietic Stem Cell Transplantation